Low PBX2 expression was associated with better prognosis in ESCC patients. Knockdown of PBX2 inhibited tumour growth and induced apoptosis of ESCC cells by decreasing Bcl‐2 expression. This evidence concerns the gene BCL2 and esophageal squamous cell carcinoma.